CD8A and systemic lupus erythematosus: Consistent with this, our study linking type I IFNs to CD8+ T metabolic fitness and survival advocates that the underlying disease mechanisms between IFN-High and IFN-Neg SLE patients may be different and thus patient stratification based on IFN signature should be considered for treating SLE patients.